What is Anika Therapeutics's net change in cash?

Anika Therapeutics (ANIK) reported net change in cash of -$16.46M in Q1 2026.

How has Anika Therapeutics's net change in cash changed year-over-year?

Anika Therapeutics's net change in cash decreased by 334.6% year-over-year, from -$3.79M to -$16.46M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Anika Therapeutics ANIK Net Change in Cash

Net Change in Cash at other companies

StrykerSYK

-$1.13B+14.9%

VericelVCEL

$9.2M+272%

Zimmer Biomet HoldingsZBH

-$167.7M-120%

Pacira BioSciences, Inc.PCRX

-$14.24M-308%

BioventusBVS

-$15.39M+18.0%

Xtant Medical HoldingsXTNT

-$5.17M-558%

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's net change in cash?: Anika Therapeutics (ANIK) reported net change in cash of -$16.46M in Q1 2026.
How has Anika Therapeutics's net change in cash changed year-over-year?: Anika Therapeutics's net change in cash decreased by 334.6% year-over-year, from -$3.79M to -$16.46M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.